+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration



Enhanced bone morphogenetic protein-2-induced ectopic and orthotopic bone formation by intermittent parathyroid hormone (1-34) administration



Tissue Engineering. Part a 16(12): 3769-3777



Bone morphogenetic proteins (BMPs) play a central role in local bone regeneration strategies, whereas the anabolic features of parathyroid hormone (PTH) are particularly appealing for the systemic treatment of generalized bone loss. The aim of the current study was to investigate whether local BMP-2-induced bone regeneration could be enhanced by systemic administration of PTH (1-34). Empty or BMP-2-loaded poly(lactic-co glycolic acid)/poly(propylene fumarate)/gelatin composites were implanted subcutaneously and in femoral defects in rats (nā€‰=ā€‰9). For the orthotopic site, empty defects were also tested. Each of the conditions was investigated in combination with daily administered subcutaneous PTH (1-34) injections in the neck. After 8 weeks of implantation, bone mineral density (BMD) and bone volume were analyzed using microcomputed tomography and histology. Ectopic bone formation and almost complete healing of the femoral defect were only seen in rats that received BMP-2-loaded composites. Additional treatment of the rats with PTH (1-34) resulted in significantly (pā€‰<ā€‰0.05) enhanced BMD and bone volume in the BMP-2 composites at both implantation sites. Despite its effect on BMD in the humerus and vertebra, PTH (1-34) treatment had no significant effect on BMD and bone volume in the empty femoral defects and the ectopically or orthotopically implanted empty composites. Histological analysis showed that the newly formed bone had a normal woven and trabecular appearance. Overall, this study suggests that intermittent administration of a low PTH dose alone has limited potential to enhance local bone regeneration in a critical-sized defect in rats. However, when combined with local BMP-2-releasing scaffolds, PTH administration significantly enhanced osteogenesis in both ectopic and orthotopic sites.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982473

Download citation: RISBibTeXText

PMID: 20666615

DOI: 10.1089/ten.TEA.2010.0173


Related references

Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion. Journal of Bone and Joint Surgery. American Volume 96(13): E107, 2014

Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. Tissue Engineering. Part a 17(3-4): 337-348, 2011

Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline. Journal of Bone and Mineral Metabolism 22(4): 329-334, 2004

Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. Journal of Biological Chemistry 267(20): 14233-7, 1992

Effect of bone morphogenetic protein-2, demineralized bone matrix and systemic parathyroid hormone (1-34) on local bone formation in a rat calvaria critical-size defect model. Journal of Periodontal Research 48(2): 243-251, 2013

Induction of bone formation by Escherichia coli-expressed recombinant human bone morphogenetic protein-2 using block-type macroporous biphasic calcium phosphate in orthotopic and ectopic rat models. Journal of Periodontal Research 46(6): 682-690, 2012

Dexamethasone enhances osteogenic differentiation of bone marrow- and muscle-derived stromal cells and augments ectopic bone formation induced by bone morphogenetic protein-2. Plos One 10(2): E0116462, 2016

Differential control of bone formation through osteoprogenitor differentiation by parathyroid hormone and bone morphogenetic protein-7. Journal of the American Society of Nephrology 14(Abstracts Issue): 468A, November, 2003

Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone (tarrytown). 15(6): 717-723, 1994

Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal. Bone (New York) 42(1): 90-97, 2008

Bone morphogenetic proteins and parathyroid hormone-related protein are bone microenvironment factors that modulate prostate cancer -induced bone remodeling through regulation of vascular endothelial growth factor. Proceedings of the American Association for Cancer Research Annual Meeting 44: 457, July, 2003

Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 42(1): 90-97, 2007

Age effects on ectopic bone formation induced by purified bone morphogenetic protein. International Journal of Oral & Maxillofacial Surgery 28(2): 143-150, April, 1999

Changes in homeobox-containing gene expression during ectopic bone formation induced by bone morphogenetic protein. Biochemical and Biophysical Research Communications 201(2): 980-987, 1994

Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. Bone (New York) 22(2): 99-105, 1998